News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Questcor Pharmaceuticals, Inc. (Headquarters) (QSC) Reports Third Quarter Financial Results



10/24/2012 10:07:49 AM

Questcor Pharmaceuticals, Inc. (QCOR) today reported financial results for the third quarter and nine months ended September 30, 2012. Net sales for the third quarter were $140.3 million, reflecting expanded physician usage of H.P. Acthar® Gel (repository corticotropin injection) in the treatment of serious, difficult-to-treat autoimmune and inflammatory disorders. Net sales in the third quarter of 2011 were $59.8 million.

Read at Yahoo Finance


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES